NYSE Euronext (NYX) today announced trading volumes for its
global derivatives and cash equities exchanges for June 20121.
Trading volumes in June 2012 were mostly down year-over-year and
month-over-month with the exception of European cash trading, which
increased 9.9% compared to the prior year and increased 3.5%
compared to May 2012. For the second quarter, trading volumes
increased from weak first quarter 2012 levels.
Highlights
- NYSE Euronext global derivatives ADV in
June 2012 of 8.3 million contracts decreased 5.9% compared to June
2011 and decreased 10.6% from May 2012 levels.
- NYSE Euronext European derivatives
products ADV in June 2012 of 4.6 million contracts decreased 0.8%
compared to June 2011 and decreased 8.5% from May 2012. Excluding
Bclear, NYSE Liffe's trade administration and clearing service for
OTC products, European derivatives products ADV decreased 11.6%
compared to June 2011 and decreased 4.8% from May 2012 levels.
- NYSE Euronext U.S. equity options ADV
of 3.6 million contracts in June 2012 decreased 11.7% compared to
June 2011 levels and decreased 13.8% from May 2012. NYSE Euronext’s
U.S. options exchanges accounted for 25.6% of total U.S.
consolidated equity options trading in June 2012, down from 26.4%
in June 2011 and down from 26.7% in May 2012.
- NYSE Liffe U.S. ADV of approximately
90,900 contracts decreased from 97,500 contracts in June 2011, but
increased from 68,300 contracts in May 2012.
- NYSE Euronext European cash products
ADV of 1.7 million transactions in June 2012 increased 9.9%
compared to June 2011 and increased 3.5% from May 2012 levels.
- NYSE Euronext U.S. cash products
handled ADV of 1.8 billion shares in June 2012 decreased 14.7%
compared to June 2011 and decreased 2.8% compared to May 2012. NYSE
Euronext’s Tape A matched market share in June 2012 was 32.3%, down
from 36.6% in June 2011, but up from 31.9% in May 2012.
- The preliminary average net revenue per
transaction type (as defined below) for each of the primary trading
venues in the second quarter of 2012 is included below:
Preliminary Trading Venue 4Q11
1Q12 2Q12 European
Derivatives (ex. Bclear)1 $0.698 $0.659
$0.67 U.S. Derivatives2 $0.148
$0.148 $0.15 European Cash3
$0.582 $0.573 $0.51 U.S.
Cash4 $0.039 $0.043
$0.042 1 Average net revenue per
contract, excluding Bclear. 2 Average net revenue per contract.
Excludes NYSE Liffe U.S. trading volume. 3 Average net revenue per
transaction. 4 Average net revenue per 100 shares handled.
Derivatives Trading
European Derivatives
- NYSE Euronext European derivatives
products ADV in June 2012 of 4.6 million contracts decreased 0.8%
compared to June 2011 and decreased 8.5% from May 2012 levels.
- The 4.6 million in European derivatives
futures and options contracts ADV in June 2012 consisted of 2.9
million contracts executed through our full-service LIFFE CONNECT
trading platform and 1.7 million contracts, or 37.3%, executed
through Bclear, NYSE Liffe's trade administration and clearing
service for OTC products. Excluding Bclear, NYSE Liffe's trade
administration and clearing service for OTC products, European
derivatives products ADV decreased 11.6% compared to June 2011 and
decreased 4.8% compared to May 2012.
- In the second quarter of 2012, European
derivatives products ADV of 4.7 million contracts was 12.1% below
prior year levels. The 4.7 million in futures and options contracts
ADV in the second quarter of 2012 consisted of 2.9 million
contracts executed through LIFFE CONNECT trading platform and 1.7
million contracts, or 37.5%, executed through Bclear.
- Year-to-date, European derivatives
products ADV of 4.0 million contracts was 19.7% below prior year
levels. The 4.0 million in futures and options contracts ADV
year-to-date consisted of 2.8 million contracts executed through
LIFFE CONNECT trading platform and 1.2 million contracts, or 30.1%,
executed through Bclear.
- Total fixed income products ADV of 1.9
million contracts in June 2012 decreased 11.1% from June 2011 and
decreased 9.0% from May 2012. In the second quarter of 2012, total
fixed income products ADV of 2.0 million contracts was 9.0% below
prior year levels. Year-to-date, total fixed income products ADV of
1.9 million contracts was 23.2% below prior year levels.
- Total equity products (including
Bclear) ADV of 2.6 million contracts in June 2012 increased 9.0%
compared to June 2011, but decreased 8.6% from May 2012. The 2.6
million contracts in equity products ADV in June 2012 consisted of
2.0 million contracts in individual equity products ADV and 0.6
million contracts in equity index products ADV. The 2.0 million
contracts in individual equity products ADV consisted of 1.5
million in futures contracts, which represented a 29.8% increase
compared to June 2011 and 0.5 million in options contracts, which
represented a 16.6% decrease compared to June 2011. The average net
rate per contract for individual equity futures contracts is
significantly lower than other European derivatives products. In
the second quarter of 2012, total equity products ADV of 2.6
million contracts were 14.4% below prior year levels. Year-to-date,
total equity products ADV of 2.0 million contracts was 16.7% below
prior year levels.
- Total commodities products ADV of
approximately 82,000 contracts in June 2012 decreased 12.6%
compared to June 2011, but increased 11.3% compared to May 2012. In
the second quarter of 2012, total commodities product ADV of 78,000
contracts was 7.1% below prior year levels. Year-to-date, total
commodities product ADV of 80,000 contracts was 7.2% below prior
year levels.
U.S. Derivatives
- NYSE Euronext U.S. equity options ADV
of 3.6 million contracts in June 2012 decreased 11.7% compared to
June 2011 and decreased 13.8% compared to May 2012. In the second
quarter of 2012, U.S. equity options ADV of 3.9 million contracts
was 3.4% below prior year levels. Year-to-date, U.S. equity options
ADV of 4.0 million contracts was 5.0% below prior year levels.
- Total U.S. consolidated equity options
ADV decreased 8.9% to 14.2 million contracts in June 2012 compared
to June 2011 and decreased 9.9% compared to May 2012. In the second
quarter of 2012, U.S. consolidated equity options ADV of 14.9
million contracts was 5.4% below prior year levels. Year-to-date,
U.S. consolidated equity options ADV of 15.4 million contracts was
6.9% below prior year levels.
- NYSE Euronext’s U.S. options exchanges
accounted for 25.6% of total U.S. consolidated equity options
trading in June 2012, down from 26.4% in June 2011 and down from
26.7% in May 2012.
- NYSE Liffe U.S. ADV of approximately
90,900 contracts decreased from 97,500 contracts in June 2011, but
increased from 68,500 contracts in May 2012. In the second quarter
of 2012, U.S. futures and futures options ADV of 73,400 contracts
was 21.5% below prior year levels. Year-to-date, U.S. futures and
futures options ADV of 84,700 contracts was 48.1% above prior year
levels.
Cash Trading
European Cash
- NYSE Euronext European cash products
ADV of 1.7 million transactions in June 2012 increased 9.9%
compared to June 2011 and increased 3.5% compared to May 2012.
- In the second quarter of 2012, European
cash products ADV of 1.7 million transactions was 11.0% above prior
year levels.
- Year-to-date, European cash products
ADV of 1.6 million transactions was 1.7% below prior year
levels.
U.S. Cash
- NYSE Euronext U.S. cash products
handled ADV in June 2012 decreased 14.7% to 1.8 billion shares
compared to June 2011 and decreased 2.8% from May 2012.
- In the second quarter of 2012, U.S.
cash products handled ADV was 1.8 billion shares, down 12.3% from
prior year levels.
- Year-to-date, U.S. cash products
handled ADV was 1.8 billion shares, down 17.8% from prior year
levels.
- NYSE Euronext’s Tape A matched market
share in June 2012 was 32.3%, down from 36.6% in June 2011, but up
from 31.9% in May 2012.
Exchange Traded Funds
- NYSE Euronext U.S. matched
exchange-traded funds ADV (included in volumes for Tape B and Tape
C) of 245 million shares in June 2012 decreased 16.2% compared to
June 2011 and decreased 2.6% compared to May 2012.
- In the second quarter of 2012, NYSE
Euronext U.S. matched exchange-traded funds ADV of 238 million
shares was 14.2% below prior year levels.
- Year-to-date, NYSE Euronext U.S.
matched exchange-traded funds ADV of 230 million shares was 18.0%
below prior year levels.
Other Metrics
- The wind-down of NYSE Blue completed in
April 2012 will lower quarterly revenue (other revenue) by $4
million and lower costs by $5 million beginning in the second
quarter of 2012.
- The non-GAAP effective tax rate for the
second quarter of 2012 is anticipated to be 25%.
- The loss attributable to NYSE
Euronext’s non-controlling interest in the NYSE Liffe U.S. is
anticipated to be lower in the second quarter of 2012 as a result
of cost control efforts.
- During the second quarter of 2012, a
total of 6.9 million shares were repurchased at an average price of
$25.60. The current $552 million stock repurchase authorization has
$248 million remaining as of June 30, 2012. As a result of these
repurchases, the weighted average diluted shares outstanding in the
second quarter was 253 million shares.
- The average EUR/USD exchange rate for
the second quarter of 2012 of $1.28 represented a decrease of 2.1%
from the first quarter of 2012 and a decrease of 10.8% compared to
the second quarter of 2011. The average GBP/USD exchange rate for
the second quarter of 2012 of $1.58 represented an increase of 0.7%
from the first quarter of 2012 and a decrease of 3.0% compared to
the second quarter of 2011.
Please click here for the Monthly Transaction Activity Data
Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial
markets and provider of innovative trading technologies. The
company's exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With
approximately 8,000 listed issues (excluding European Structured
Products), NYSE Euronext's equities markets – the New York Stock
Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca –
represent one-third of the world's equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates
NYSE Liffe, one of the leading European derivatives businesses and
the world's second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology,
connectivity and market data products and services through NYSE
Technologies. NYSE Euronext is in the S&P 500 index, and is the
only exchange operator in the Fortune 500. For more information,
please visit: http://www.nyx.com.
Disclaimer and Cautionary Note Regarding Forward-Looking
Statements
This press release may contain forward-looking statements,
including forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such
forward-looking statements include, but are not limited to,
statements concerning NYSE Euronext's plans, objectives,
expectations and intentions and other statements that are not
historical or current facts. Forward-looking statements are based
on NYSE Euronext's current expectations and involve risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied in such forward-looking statements.
Factors that could cause NYSE Euronext's results to differ
materially from current expectations include, but are not limited
to: NYSE Euronext's ability to implement its strategic initiatives,
economic, political and market conditions and fluctuations,
government and industry regulation, interest rate risk and U.S. and
global competition, and other factors detailed in NYSE Euronext's
2011 Annual Report on Form 10-K and other periodic reports filed
with the U.S. Securities and Exchange Commission or the French
Autorité des Marchés Financiers. In addition, these statements are
based on a number of assumptions that are subject to change.
Accordingly, actual results may be materially higher or lower than
those projected. The inclusion of such projections herein should
not be regarded as a representation by NYSE Euronext that the
projections will prove to be correct. This press release speaks
only as of this date. NYSE Euronext disclaims any duty to update
the information herein.
1 All NYSE Euronext derivatives transactions count buy and sell
orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy
and sell orders together as a single transaction.
NYSE
Euronext
Monthly Volume
Summary
Average Daily Volume
Total Volume
AverageDaily
Volume
Total Volume (Unaudited; contracts in
thousands)
Jun-12 Jun-11
% Chg Jun-12
Jun-11 % Chg YTD
2012
% Chg vs.
YTD
2011
YTD 2012
% Chg
vs.YTD 2011
Number of Trading Days - European Cash
21 22 21 22 127 127 Number of Trading Days - European Derivatives
21 22 21 22 128 128 Number of Trading Days - U.S. Markets 21 22 21
22 125 125
European Derivatives Products 4,597
4,634 -0.8% 96,544 101,957 -5.3%
3,983 -19.7% 509,777 -19.1% of which
Bclear 1,714 1,373 24.8% 35,998 30,217 19.1% 1,200 -16.8% 153,556
-16.2%
Total Fixed Income Products 1,924
2,163 -11.1% 40,401 47,583
-15.1% 1,862 -23.2% 238,387
-22.6% Short Term Interest Rate Products 1,783 2,025
-11.9% 37,451 44,540 -15.9% 1,710 -25.3% 218,917 -24.7% Medium and
Long Term Interest Rate Products 1 140 138 1.6% 2,950 3,043 -3.0%
152 11.6% 19,469 12.5%
Total Equity Products 2
2,592 2,378 9.0% 54,432 52,322
4.0% 2,040 -16.7% 261,162 -16.0%
Individual Equity Products 2,005 1,754 14.3% 42,111 38,582
9.1% 1,534 -19.1% 196,328 -18.4% Futures 1,517 1,168 29.8% 31,854
25,702 23.9% 1,048 -17.7% 134,137 -17.1% Options 488 585 -16.6%
10,257 12,880 -20.4% 486 -21.9% 62,191 -21.2% Equity Index Products
587 625 -6.1% 12,321 13,741 -10.3% 507 -8.6% 64,834 -7.9% of
which Bclear 1,714 1,373 24.8% 35,998 30,217 19.1% 1,200 -16.8%
153,556 -16.2% Individual Equity Products 1,621 1,263 28.4% 34,044
27,776 22.6% 1,125 -17.6% 144,023 -17.0% Futures 1,512 1,168 29.5%
31,759 25,696 23.6% 1,023 -18.7% 130,972 -18.1% Options 109 95
15.0% 2,284 2,080 9.8% 102 -4.9% 13,051 -4.1% Equity Index Products
93 111 -16.1% 1,955 2,441 -19.9% 74 -2.8% 9,533 -2.1%
Commodity Products 82 93 -12.6%
1,712 2,051 -16.6% 80 -7.2%
10,228 -6.5% U.S. Derivatives Products
Equity Options 3 NYSE Euronext Options
Contracts 3,624 4,105 -11.7% 76,103 90,301 -15.7% 4,020 -5.0%
502,556 -5.0% Total Consolidated Options Contracts 14,183 15,570
-8.9% 297,841 342,531 -13.0% 15,391 -6.9% 1,923,930 -6.9%
NYSE Group Share of Total 25.6% 26.4% 25.6% 26.4% 26.1% 0.5% 26.1%
0.5%
NYSE Liffe U.S. Futures and Futures
Options Volume* 90.9 97.5 -6.8% 1,908 2,145 -11.1% 84.7 48.1%
10,930.6 49.2%
European Cash Products (trades in
thousands) 1,668 1,518 9.9% 35,034
33,396 4.9% 1,645 -1.7% 208,861
-1.7% Equities 1,617 1,461 10.7% 33,966 32,146 5.7%
1,591 -1.0% 202,107 -1.0% Exchange-Traded Funds 14 17 -20.4% 287
377 -24.0% 14 -22.0% 1,831 -22.0% Structured Products 32 35 -8.5%
668 765 -12.7% 34 -16.9% 4,294 -16.9% Bonds 5 5 10.6% 114 108 5.6%
5 -5.9% 628 -5.9%
U.S. Cash Products (shares in
millions) 5 1,837 2,153 -14.7%
38,580 47,362 -18.5% 1,801
-17.8% 225,100 -17.8% NYSE Listed
(Tape A) Issues 4 Handled Volume 5 1,323 1,525
-13.3% 27,782 33,556 -17.2% 1,287 -17.7% 160,922 -17.7% Matched
Volume 6 1,264 1,450 -12.8% 26,554 31,902 -16.8% 1,219 -17.7%
152,355 -17.7% Total NYSE Listed Consolidated Volume 3,918 3,961
-1.1% 82,268 87,140 -5.6% 3,906 -8.1% 488,298 -8.1%
Share
of Total Consolidated Volume Handled Volume 5 33.8% 38.5% -4.7%
33.8% 38.5% -4.7% 33.0% -3.8% 33.0% -3.8% Matched Volume 6 32.3%
36.6% -4.3% 32.3% 36.6% -4.3% 31.2% -3.6% 31.2% -3.6%
NYSE Arca, MKT and Regional (Tape B)
Listed
Issues
Handled Volume 5 288 354 -18.6% 6,046 7,779 -22.3% 272
-20.2% 33,960 -20.2% Matched Volume 6 261 320 -18.4% 5,478 7,032
-22.1% 243 -20.4% 30,433 -20.4% Total NYSE Arca & MKT Listed
Consolidated Volume 1,212 1,347 -10.0% 25,443 29,629 -14.1% 1,155
-12.4% 144,402 -12.4%
Share of Total Consolidated
Volume Handled Volume 5 23.8% 26.3% -2.5% 23.8% 26.3% -2.5%
23.5% -2.3% 23.5% -2.3% Matched Volume 6 21.5% 23.7% -2.2% 21.5%
23.7% -2.2% 21.1% -2.1% 21.1% -2.1%
Nasdaq Listed (Tape
C) Issues Handled Volume 5 226 274 -17.4% 4,752 6,026
-21.1% 242 -15.8% 30,218 -15.8% Matched Volume 6 196 233 -16.1%
4,109 5,131 -19.9% 206 -15.6% 25,726 -15.6% Total Nasdaq Listed
Consolidated Volume 1,790 2,021 -11.4% 37,595 44,468 -15.5% 1,799
-11.1% 224,885 -11.1%
Share of Total Consolidated
Volume Handled Volume 5 12.6% 13.6% -1.0% 12.6% 13.6% -1.0%
13.4% -0.8% 13.4% -0.8% Matched Volume 6 10.9% 11.5% -0.6% 10.9%
11.5% -0.6% 11.4% -0.7% 11.4% -0.7%
Exchange-Traded
Funds 5,7 Handled Volume 5 271 324 -16.6% 5,684
7,137 -20.4% 257 -17.7% 32,100 -17.7% Matched Volume 6 245 292
-16.2% 5,140 6,426 -20.0% 230 -18.0% 28,714 -18.0% Total ETF
Consolidated Volume 1,181 1,278 -7.6% 24,792 28,111 -11.8% 1,126
-8.3% 140,693 -8.3%
Share of Total Consolidated
Volume Handled Volume 5 22.9% 25.4% -2.5% 22.9% 25.4% -2.5%
22.8% -2.6% 22.8% -2.6% Matched Volume 6 20.7% 22.9% -2.2% 20.7%
22.9% -2.2% 20.4% -2.4% 20.4% -2.4%
1 Data includes currency
products.
2 Includes all trading activities
for Bclear, NYSE Liffe's clearing service for wholesale
derivatives.
3 Includes trading in
U.S. equity options contracts, not equity-index options.
4 Includes all volume
executed in NYSE Group crossing sessions.
5 Represents the total
number of shares of equity securities and ETFs internally matched
on the NYSE Group's exchanges or routed to and
executed at an external
market center. NYSE Arca routing includes odd-lots.
6 Represents the total
number of shares of equity securities and ETFs executed on the NYSE
Group's exchanges.
7 Data included in
previously identified categories.
* ADVs calculated with
the appropriate number of NYSE Liffe U.S. trading days.
Source: NYSE Euronext,
Options Clearing Corporation and Consolidated Tape as reported for
equity securities.
All trading activity is
single-counted, except European cash trading which is double
counted to include both buys and sells.
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Lug 2023 a Lug 2024